Use of USPIO-induced magnetic susceptibility artifacts to identify sentinel lymph nodes and lymphatic drainage patterns. I. Dependence of artifact size with subcutaneous Combidex dose in rats.

[1]  L. Adler,et al.  Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET. , 1997, Radiology.

[2]  A Horsman,et al.  Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging. , 1997, Radiology.

[3]  T. Yeatman,et al.  Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. , 1996, JAMA.

[4]  M. Ross,et al.  Surgical management of stage I and II melanoma patients: approach to the regional lymph node basin. , 1996, Seminars in surgical oncology.

[5]  I. Liem,et al.  Reproducibility of lymphoscintigraphy for lymphatic mapping in cutaneous melanoma. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  H. Wahner,et al.  Filtered technetium-99m-sulfur colloid evaluated for lymphoscintigraphy. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  J. Thompson,et al.  Mammary lymphoscintigraphy in breast cancer. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  R. Weissleder,et al.  MR Lymphography with a Lymphotropic T1‐Type MR Contrast Agent: Gd‐DTPA‐PGM , 1995, Magnetic resonance in medicine.

[9]  C. O'brien,et al.  Lymphoscintigraphy to identify sentinel lymph nodes in patients with melanoma , 1994, Melanoma research.

[10]  J A Koutcher,et al.  AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes. , 1994, Radiology.

[11]  W. Yuh,et al.  Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. , 1994, Radiology.

[12]  R Weissleder,et al.  MR lymphography: study of a high-efficiency lymphotrophic agent. , 1994, Radiology.

[13]  R. Henkelman,et al.  Cavernous hemangiomas: dipolar susceptibility artifacts at MR imaging. , 1993, Radiology.

[14]  R. Weissleder,et al.  Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. , 1990, Radiology.

[15]  R Weissleder,et al.  Experimental lymph node metastases: enhanced detection with MR lymphography. , 1989, Radiology.

[16]  D. Harpole,et al.  Radionuclide lymphoscintigraphy with technetium 99m antimony sulfide colloid to identify lymphatic drainage of cutaneous melanoma at ambiguous sites in the head and neck and trunk , 1985, Cancer.

[17]  G. Hör,et al.  Axillary lymph node groups--the center in lymphatic drainage from the truncal skin in man. Clinical significance for management of malignant melanoma. , 1982, Lymphology.

[18]  Tilney Nl.  Patterns of lymphatic drainage in the adult laboratory rat. , 1971 .

[19]  M. Moerland,et al.  Simulation of susceptibility artifacts in 2D and 3D Fourier transform spin-echo and gradient-echo magnetic resonance imaging. , 1994, Magnetic resonance imaging.

[20]  L. Josephson,et al.  Visualization of superior mesenteric lymph nodes by the combined oral and intravenous administration of the ultrasmall superparamagnetic iron oxide, AMI-227. , 1994, Magnetic resonance imaging.

[21]  B. Hamm,et al.  MR lymphography with iron oxide particles: dose-response studies and pulse sequence optimization in rabbits. , 1992, AJR. American journal of roentgenology.